Literature DB >> 1936520

Identification of multiple transcription start sites in the human insulin-like growth factor-I gene.

E Jansen1, P H Steenbergh, D LeRoith, C T Roberts, J S Sussenbach.   

Abstract

We have localized four transcription initiation sites in the human insulin-like growth factor-I (IGF-I) gene. Two transcription start sites were identified which result in a longer and shorter version of the leader derived from the known exon 1 of the IGF-I gene. Transcription starting at the upstream transcription initiation site results in a leader exon 1 of about 1155 nucleotides (nt), whereas transcription starting at the downstream initiation site results in a leader of about 240 nt. The majority of the transcripts initiate at the latter site. We further identified a region in the human IGF-I gene between exons 1 and 2, which shows a high degree of homology with the rat IGF-I leader exon 1B. By means of the polymerase chain reaction (PCR) we detected human IGF-I mRNAs containing this novel leader. The corresponding exon was designated exon 1B according to the rat IGF-I gene terminology. PCR and RNase protection analyses identified two transcription start sites within this alternative leader exon 1B. Transcription initiated at the most upstream start site results in a leader of about 750 nt, whereas transcription starting at the downstream site is heterogeneous, resulting in leaders of 65-75 nt long. No consensus TATA-box or AT-rich regions are present immediately upstream of all four transcription start sites identified, nor are these regions particularly GC-rich. The IGF-I gene is known to be expressed differentially in a tissue- and development-specific fashion. Differential activation of multiple promoters could very well play a crucial role in IGF-I gene regulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936520     DOI: 10.1016/0303-7207(91)90192-u

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

Review 1.  The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity.

Authors:  Anastassios Philippou; Maria Maridaki; Spiros Pneumaticos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-05-07       Impact factor: 6.354

2.  Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch.

Authors:  S Yang; M Alnaqeeb; H Simpson; G Goldspink
Journal:  J Muscle Res Cell Motil       Date:  1996-08       Impact factor: 2.698

3.  Cloning and characterization of class 1 and class 2 insulin-like growth factor-I mRNA in Songliao black pig.

Authors:  Shuqi Xiao; Shuang Li; Jiabao Zhang; Shumin Zhang; Lisheng Dai; Yonghua Bao; Ning Jiang; Yan Gao; Zhongli Zhao; Delin Mo; Yaosheng Chen; Zhihui Zhao
Journal:  Mol Biol Rep       Date:  2007-12-23       Impact factor: 2.316

4.  The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.

Authors:  Meriem Ouni; Yasemin Gunes; Marie-Pierre Belot; Anne-Laure Castell; Delphine Fradin; Pierre Bougnères
Journal:  Clin Epigenetics       Date:  2015-03-13       Impact factor: 6.551

5.  The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness.

Authors:  M Ouni; M P Belot; A L Castell; D Fradin; P Bougnères
Journal:  Pharmacogenomics J       Date:  2015-04-14       Impact factor: 3.550

Review 6.  Role of Alternatively Spliced Messenger RNA (mRNA) Isoforms of the Insulin-Like Growth Factor 1 (IGF1) in Selected Human Tumors.

Authors:  Aldona Kasprzak; Witold Szaflarski
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.